| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/04/2005 | US20050171068 Novel 4-dedimethylaminotetracycline derivatives |
| 08/04/2005 | US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma |
| 08/04/2005 | US20050171062 Administering to an animal having ocular hypertension or inflammatory bowel disease a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester |
| 08/04/2005 | US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 08/03/2005 | EP1559715A1 N-[2-chloro-4-(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 08/03/2005 | EP1559422A1 Receptor function controlling agent |
| 08/03/2005 | EP1559420A1 Treatment of tinnitus |
| 08/03/2005 | EP1558264A2 Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases |
| 08/03/2005 | EP1558254A2 A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye, compositions resulting therefrom |
| 08/03/2005 | EP1359975A4 Ocular iontophoretic device and method of use |
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1330166B1 Food grade transglutaminase inhibitor and uses thereof |
| 08/03/2005 | EP1142890B1 Aminopyrazole derivatives |
| 08/03/2005 | EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/03/2005 | EP0639070B1 Use of borate-polyol complexes in ophthalmic compositions |
| 08/03/2005 | CN1650005A Antimicrobial polypeptide and utizliation thereof |
| 08/03/2005 | CN1650001A Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinop |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 08/03/2005 | CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives |
| 08/03/2005 | CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 08/03/2005 | CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/03/2005 | CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 08/03/2005 | CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient |
| 08/03/2005 | CN1649624A Use of TNF alpha antibodies and another drug |
| 08/03/2005 | CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 08/03/2005 | CN1649599A Substituted aminoalkanephosphonic acids for the treatment ofneuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders |
| 08/03/2005 | CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 08/03/2005 | CN1649575A Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1647816A Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method |
| 08/03/2005 | CN1213055C Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments |
| 08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
| 08/03/2005 | CN1213029C S-Ht receptor agonist and its preparing method for salt |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1212848C L-histidine in ophthalmic solutions |
| 08/03/2005 | CN1212847C Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 08/03/2005 | CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors |
| 08/02/2005 | US6924413 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | US6924305 Diazocine derivatives and their use as tryptase inhibitors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005067907A1 Reagent for lacrimation examination and method of lacrimation examination |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164979 Pharmaceutical composition for ophthalmological and rhinological application |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050163864 Comprises vitamin C, vitamin E, vitamin A (beta-carotene), zinc oxide, and cupric oxide; for promotion of retinal health |
| 07/28/2005 | US20050163809 Remedy for hypermyotonia |
| 07/28/2005 | DE10360425A1 Compositions containing hyaluronic acid or its derivatives as sole active agent, useful for topical treatment of ophthalmological or rhinological allergic complications |
| 07/28/2005 | DE10359384A1 Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor Use of an extract of Aloysia triphylla as a matrix protector |
| 07/28/2005 | CA2553711A1 Reagent for lacrimation examination and method of lacrimation examination |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552521A1 Compositions comprosing memantine and polyanionic polymers for administration to the eye |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1455803B1 Pharmaceutical composition for use in ophthalmology and rhinology |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646500A Aryl substituted pyrimidines and the use thereof |